Table 4 Cost-effectiveness incremental analysis of the strategies for treatment of 64 severe asthma patients
From: Cost-effectiveness analysis of a state funded programme for control of severe asthma
Strategies | Costs (US$) | Hospitalizations | Health Result | Incremental Cost (US$) | Cost-effectiveness incremental |
|---|---|---|---|---|---|
(C-D) | (B-A) | (F/E) | |||
Intervention 1 | |||||
The usual treatment of severe asthma offered by the public health system with medication for exacerbations | 173,440 (A) | 85 (C) | |||
Intervention 2 | |||||
Treatment of severe asthma offered by ProAR with inhaled corticosteroid + long acting bronchodilator | 56,256 (B) | 1 (D) | 84 (E) | -117,184 (F) | -1,395 |